Search Results - "Holland, P.V"

O.023 Transfusion associated hepatitis B virus infections by Holland, P.V.

Get full text

Platelet bacterial contamination and the use of a chemiluminescence-linked universal bacterial ribosomal RNA gene probe by Brecher, M E, Hogan, J J, Boothe, G, Kerr, A, McClannan, L, Jacobs, M R, Yomtovian, R, Chongokolwatana, V, Tegtmeier, G, Henderson, S

“…Currently, the maximum outdate for platelets is 5 days, because of the increasing chance of bacterial growth over time. Various methods for rapid detection of…”
Get more information

Donor cell induced CD69 expression and intracellular IL-2 and IL-4 production by peripheral blood lymphocytes isolated from kidney transplant recipients by Paglieroni, T.G, Perez, R, Katznelson, S, Muto, K, Chang, T, Scott, S, MacKenzie, M.R, Holland, P.V

“…Flow cytometry assays, which measure CD69 activation and intracellular cytokine production, have been used to measure peripheral blood lymphocyte (PBL)…”
Get full text

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test by Kleinman, S.H., Strong, D.M., Tegtmeier, G.G.E., Holland, P.V., Gorlin, J.B., Cousins, C., Chiacchierini, R.P, Pietrelli, L.A.

“…BACKGROUND: The risk of hepatitis B virus (HBV) transmission by blood transfusion (estimated at 1 in 63,000‐1 in 205,000 units in the United States) exceeds…”
Get full text

Alloimmunization in two multitransfused patient populations by Coles, S M, Klein, H G, Holland, P V

“…A retrospective study was undertaken to determine the frequency of alloimmunization in two multitransfused patient populations. Three hundred eighteen…”
Get more information

Visual assessment of hemolysis in red blood cell units and segments can be deceptive by Janatpour, K.A., Paglieroni, T.G., Crocker, V.L., DuBois, D.J., Holland, P.V.

“…BACKGROUND:  Blood components that appear hemo‐lyzed are discarded. However, visual inspection is subjec‐tive and criteria for excessive hemolysis are poorly…”
Get full text

Press Review by Engelfriet, C.P., Kopke, P.M., Holland, P.V.

“…Transfusion‐Related Acute Lung Injury…”
Get full text

Post-Transfusion Hepatitis: Current Risks and Causes by Holland, P.V.

“…Viral hepatitis which follows transfusions (post‐transfusion hepatitis) may be due to those transfusions, i.e., transfusion‐transmitted hepatitis (TTH), or may…”
Get full text

Mechanisms of severe transfusion reactions by Kopko, P.M, Holland, P.V

“…Serious adverse effects of transfusion may be immunologically or non-immunologically mediated. Currently, bacterial contamination of blood products,…”
Get full text

Circannual variation in lymphocyte subsets, revisited by Paglieroni, T G, Holland, P V

“…Circadian and circannual variations in lymphocyte subsets, especially CD8+ T-lymphocytes, have been reported. This study focuses on CD4+ T-lymphocyte seasonal…”
Get more information

The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview by Busch, M P, Collier, A, Gernsheimer, T, Carrington, J D, Flanigan, T P, Kashkari, M, Kennedy, M, Kumar, P N, Lane, T A, Mellors, J W, Mohandas, K, Pollard, R B, Viele, M, Yomtovian, R, Holland, P V, McCurdy, P R

Get more information

Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine by Aoki, S K, Finegold, D, Kuramoto, I K, Douville, C, Richards, C, Randell, R, Fernando, L, Holland, P V, Zeldis, J B

“…Because large numbers of volunteer blood donors may be disqualified for "false-positive" results on tests for antibody to hepatitis B core antigen (anti-HBc),…”
Get more information

Staff costs associated with the implementation of a comprehensive compliance program in a community blood center by Smith, E N, Holland, P V, Holliman, S M, Fuller, M J

Get more information

Screening of blood donors for idiopathic CD4+ T-lymphocytopenia by Busch, M P, Valinsky, J E, Paglieroni, T, Prince, H E, Crutcher, G J, Gjerset, G F, Operskalski, E A, Charlebois, E, Bianco, C, Holland, P V

“…The recent recognition of idiopathic CD4+ T-lymphocytopenia (ICL) had led to concern that an unknown immunodeficiency virus may be transmissible by…”
Get more information

Evidence of Hepatitis in Patients Receiving Transfusions of Blood Components Containing Antibody to Hepatitis C by Aoki, S.K., Holland, P.V., Fernando, L.P., Kuramoto, I.K., Anderson, S., Sazama, K., Schoening, V., Johnson, P., Wilber, J.C., Fenner, L., Alter, H.J.

“…When hepatitis C virus antibody (anti-HCV) enzyme immunoassay (EIA1) testing became available in 1990, we tested samples from previously transfused blood…”
Get full text

How far shall we go in the predonation selection of blood donors to safeguard patients for blood-transfusion-related infections?

Get more information

Idiopathic CD4+ T-lymphocytopenia (ICL) and the safety of blood transfusions: what do we know and what should we do? by Busch, M P, Holland, P V

Get more information

Effects of serial plasmapheresis on serum IgA levels in IgA-deficient blood donors with IgA-suppressor T cells by Paglieroni, T G, Holland, P V

“…Seventeen IgA-deficient blood donors, without antibodies to IgA, underwent plasmapheresis four to eight consecutive times at intervals of 8 weeks or less to…”
Get more information

Detection of antibodies to human immunodeficiency virus type 2 (HIV-2) in blood donor sera using United States assay methods for anti-HIV type 1 by Sazama, K, Kuramoto, I K, Holland, P V, Couroucé, A M, Gallo, D, Hanson, C V

“…Twelve serum samples from French blood donors that were uniformly reactive in tests for antibody to human immunodeficiency virus type 2 (anti-HIV-2) also were…”
Get more information

Which are the principal established or potential risks for donors undergoing cytapheresis procedures and how can they be prevented?

Get more information